Published Date:2025-01-17 Original Link:https://www.onenessbio.com/en/news_detail332_3.htm No 1 Date of announcement 2025/01/17 Time of announcement 17:39:27 Subject Oneness Biotech Co., Ltd. receives a Chinese patent titled “TREATING IGE-MEDIATED ALLERGIC DISEASES”on FB825. To which item it meets paragraph 53 Date of events 2025/01/17 Statement Date of occurrence of the event: 2025/01/17 Company name: ONENESS BIOTECH CO., LTD Relationship...Read More

Published Date:2025-01-10 Original Link:https://www.onenessbio.com/en/news_detail331_3.htm No 1 Date of announcement 2025/01/10 Time of announcement 17:46:26 Subject Oneness Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference To which item it meets paragraph 12 Date of events 2025/01/17 Statement 1.Date of institutional investor conference: 2025/01/17 2.Time of institutional investor conference: 06:45 (CST) 3.Location of institutional...Read More

Published Date:2025-01-09 Original Link:https://www.onenessbio.com/en/news_detail330_3.htm No 1 Date of announcement 2025/01/09 Time of announcement 18:14:15 Subject Oneness Nanchou manufacturing site has passed the GMP compliance assessment of foreign pharmaceutical manufacturers reviewed by the DAV To which item it meets paragraph 53 Date of events 2025/01/09 Statement Date of occurrence of the event: 2025/01/09 Company name: Oneness...Read More

Published Date:2024-12-17 Original Link:https://www.onenessbio.com/en/news_detail329_1.htm No 1 Date of announcement 2024/12/17 Time of announcement 16:59:09 Subject Oneness announces the information about the investor’s conference of 2024 Q4. To which item it meets paragraph 12 Date of events 2024/12/24 Statement Date of institutional investor conference: 2024/12/24 Time of institutional investor conference: 15:00 (GMT+8) Location of institutional investor...Read More

Published Date:2024-11-12 Original Link:https://www.onenessbio.com/en/news_detail328_1.htm No 1 Date of announcement 2024/11/12 Time of announcement 18:58:59 Subject (Supplementary Explanation) Announcement of the Company’s board of directors’ resolution on the change of the cash capital increase plan for 2020 To which item it meets paragraph 16 Date of events 2024/11/11 Statement Date of the board of directors resolution...Read More

Published Date:2024-11-11 Original Link:https://www.onenessbio.com/en/news_detail327_1.htm No 3 Date of announcement 2024/11/11 Time of announcement 17:27:21 Subject Announcement of the Company’s board of directors’ resolution on the change of the cash capital increase plan for 2020 To which item it meets paragraph 16 Date of events 2024/11/11 Statement Date of the board of directors resolution for the...Read More

Published Date:2024-11-11 Original Link:https://www.onenessbio.com/en/news_detail326_1.htm No 1 Date of announcement 2024/11/11 Time of announcement 17:04:57 Subject The Company’s 2024Q3 consolidated financial statements have been approved by the Board of Directors To which item it meets paragraph 31 Date of events 2024/11/11 Statement Date of the board of directors submitted or approved: 2024/11/11 Date of the audit...Read More

Published Date:2024-11-04 Original Link:https://www.onenessbio.com/en/news_detail325_1.htm No 1 Date of announcement 2024/11/04 Time of announcement 20:51:08 Subject Bonvadis topical cream received medical device marketing authorization approval for all indications in wounds for Saudi Arabia To which item it meets paragraph 10 Date of events 2024/11/04 Statement Date of occurrence of the event: 2024/11/04 New drug name or...Read More

Published Date:2024-10-30 Original Link:https://www.onenessbio.com/en/news_detail324_1.htm No 1 Date of announcement 2024/10/30 Time of announcement 17:46:52 Subject Announcement of the date of the Company’s board of directors meeting for the Thired Quarter of 2024 Consolidated Financial Reports To which item it meets paragraph 31 Date of events 2024/10/30 Statement Date of a notice of the board of...Read More

Published Date:2024-09-27 Original Link:https://www.onenessbio.com/en/news_detail323_1.htm No 2 Date of announcement 2024/09/27 Time of announcement 17:34:49 Subject A US patent titled “Biomarkers for lung cancer stem cells” has been granted To which item it meets paragraph 53 Date of events 2024/09/27 Statement Date of occurrence of the event: 2024/09/27 Company name: ONENESS BIOTECH CO., LTD. Relationship to...Read More